Skip Navigation


Radiation Protection Dosimetry Advance Access originally published online on September 24, 2007
Radiation Protection Dosimetry 2007 127(1-4):430-434; doi:10.1093/rpd/ncm408
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
127/1-4/430    most recent
ncm408v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lee, J.-I.
Right arrow Articles by Lee, J.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J.-I.
Right arrow Articles by Lee, J.-K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Usefulness of the simultaneous bioassay analysis method used for an intake estimation of a radionuclide

Jong-Il Lee1,2,* and Jai-Ki Lee2

1 Korea Atomic Energy Research Institute, PO Box 105, Yuseong-gu, Daejeon, Republic of Korea
2 Hanyang University, 17 Haengdang-dong, Seondong-gu, Seoul, Republic of Korea

* Corresponding author: jilee2{at}kaeri.re.kr

An intake of a radionuclide is estimated based on bioassay measurement data obtained by an in vivo or an in vitro method. Often the intake estimates from one bioassay analysis are considerably different from other results. For better estimates, a simultaneous or combined analysis of measurement data from different bioassay methods is attempted. In this study, the usefulness of a simultaneous bioassay analysis was investigated by using the IDEAS/IAEA intercomparison exercise data and the Individual Monitoring of an Internal Exposure computer code. Tests were made for whole-body counting and urine assay against an acute inhalation of types M and S 60Co particles with various activity median aerodynamic diameter (AMAD). The data set excluding rogue data as well as all the available data were used in this study. The best estimated intake was evaluated based on the best-fit time of an intake determined by minimizing the mean relative deviation Dr. In the case of the whole-body and urine bioassay by using the data excluding some rogue data, the smallest Dr appears at 0.1 and 10 µm of AMAD, respectively, which are different from those estimated by using all the available data. In the case of the simultaneous analysis, it appears at 20 µm of AMAD, which is the same as that estimated by using all the available data. Supposing that monitoring data of a good quality is available, it is expected that the application of a simultaneous analysis to different bioassay methods can provide not only better estimates of an intake but also insights into the validity of the models and parameters used in an interpretation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.